AQAMAN, a Bisamidine-Based Inhibitor of Toxic Protein Inclusions in Neurons, Ameliorates Cytotoxicity in Polyglutamine Disease Models

Journal of Biological Chemistry - United States
doi 10.1074/jbc.ra118.006307
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Biochemistry & Molecular Biology (ASBMB)

Related search

Identification of a Polyglutamine Protein Aggregation Inhibitor QAI1 and Its Therapeutic Effects on Polyglutamine Neurodegenerative Diseases.

Proceedings for Annual Meeting of The Japanese Pharmacological Society
2020English

Toward Understanding the Role of Protein Context in the Polyglutamine Disease, SCA3

English

CAG Repeat RNA as an Auxiliary Toxic Agent in Polyglutamine Disorders

RNA Biology
Cell BiologyMolecular Biology
2011English

Conformational Studies of Pathogenic Expanded Polyglutamine Protein Deposits From Huntington’s Disease

Experimental Biology and Medicine
MedicineBiochemistryGeneticsMolecular Biology
2019English

Differential Recruitment of UBQLN2 to Nuclear Inclusions in the Polyglutamine Diseases HD and SCA3

Neurobiology of Disease
Neurology
2015English

Expression of Apoptosis Inhibitor Protein McL1 Linked to Neuroprotection in CNS Neurons

Cell Death and Differentiation
Cell BiologyMolecular Biology
2004English

CRMP5-associated GTPase (CRAG) Protein Protects Neuronal Cells Against Cytotoxicity of Expanded Polyglutamine Protein Partially via C-Fos-Dependent Activator Protein-1 Activation

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2011English

Restoration of CREB Function Ameliorates Cisplatin Cytotoxicity in Renal Tubular Cells

American Journal of Physiology - Renal Physiology
UrologyPhysiology
2008English

Application of Cytotoxicity Test for Toxic Micropollutants.

Journal of Japan Society on Water Environment
1992English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy